HQY insider buying and SEC filings, explained
Healthequity, Inc. · CIK 1428336
Tracked: Forms 3/4/5, 8-K, NT · All filings on sec.gov
Insider activity in the last 12 months
Bought
$12K
Insiders who bought
1
Sold (not marked 10b5-1)
$1.1M
Planned sales (10b5-1)
$2.7M
Insider purchases and sales, last 12 months
| Traded | Type | What was filed | Source |
|---|---|---|---|
| Apr 22–Aug 24, 2026 | Sale | Sunil Rajasekar (EVP Chief Prod & Strat Officer) sold 131 shares between Apr 22 and Aug 24 at about $101.60 ($13K). Holdings down <1% to 53,297 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed Oct 19, 2026, 5:30 PM ET |
| Jul 8–Oct 15, 2026 | Purchase (code P) | Sunil Rajasekar (EVP Chief Prod & Strat Officer) bought 131 shares between Jul 8 and Oct 15 at about $91.16 ($12K), reported as a purchase (code P). Holdings up <1% to 53,405 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed Oct 19, 2026, 5:30 PM ET |
| Aug 25, 2026 | Planned (10b5-1) | Adrian T. Dillon (Director) sold 7,632 shares at about $104.61 ($798K), marked as a 10b5-1 plan trade. Holdings down 11% to 62,395 shares. | SEC filing Filed Aug 27, 2026 |
| Jul 10, 2026 | Planned (10b5-1) | Michael Henry Fiore (EVP, Chief Commercial Officer) sold 2,354 shares at $95.00 ($224K), marked as a 10b5-1 plan trade. Holdings down 4% to 52,244 shares. | SEC filing Filed Jul 14, 2026 |
| Jul 2, 2026 | Planned (10b5-1) | Michael Henry Fiore (EVP, Chief Commercial Officer) sold 2,470 shares at $95.00 ($235K), marked as a 10b5-1 plan trade. Holdings down 4% to 56,643 shares. | SEC filing Filed Jul 7, 2026 |
| May 29, 2026 | Planned (10b5-1) | Michael Henry Fiore (EVP, Chief Commercial Officer) sold 3,142 shares at $95.00 ($298K), marked as a 10b5-1 plan trade. Holdings down 5% to 59,113 shares. | SEC filing Filed Jun 2, 2026 |
| May 28, 2026 | Planned (10b5-1) | Gayle Furgurson Wellborn (Director) sold 2,439 shares at $90.00 ($220K), marked as a 10b5-1 plan trade. Holdings down 11% to 19,733 shares. | SEC filing Filed Jun 1, 2026 |
| May 28, 2026 | Planned (10b5-1) | Delano Ladd (EVP, General Counsel) sold 7,500 shares at $90.00 ($675K), marked as a 10b5-1 plan trade. Holdings down 8% to 91,141 shares. | SEC filing Filed Jun 1, 2026 |
| Dec 19, 2025 | Planned (10b5-1) | Delano Ladd (EVP, General Counsel) sold 1,500 shares at $94.72 ($142K), marked as a 10b5-1 plan trade. Holdings down 2% to 73,979 shares. | SEC filing Filed Dec 23, 2025 |
| Dec 18, 2025 | Sale | Elimelech Rosner (EVP, Chief Technology Officer) sold 10,959 shares at about $95.45 ($1.0M). Holdings down 19% to 45,742 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed Dec 19, 2025 |
| Nov 20, 2025 | Planned (10b5-1) | Delano Ladd (EVP, General Counsel) sold 1,500 shares at $104.56 ($157K), marked as a 10b5-1 plan trade. Holdings down 2% to 75,479 shares. | SEC filing Filed Nov 24, 2025 |
51 routine transactions (such as grants, option exercises or tax withholding) are not listed.
Cluster buys
No cluster buys in the last 12 months.
Red flags
No red flags in the last 12 months.
Key events
No key events in the last 12 months.
8-K filings, last 12 months
No 8-K filings in the last 12 months.
Red flags are objective triggers only: the item or form filed, never an opinion.
Follow HQY in the Insider Ledger app
Get the appA plain-English brief of insider purchases, 8-Ks and red flags at the companies you pick. No account needed.